Oral Contraceptive Market Report

Global Oral Contraceptive Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：138
  • REPORT CODE：GMM860799
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Oral Contraceptive market report explains the definition, types, applications, major countries, and major players of the Oral Contraceptive market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Janssen Global Services, LLC

    • Beijing Zizhu Pharm

    • Bayer AG

    • Merck & Co Inc

    • Mankind Pharma Ltd

    • Piramal Enterprises Ltd

    • Pfizer Inc

    • Allergan, plc (Actavis)

    • Teva Pharmaceutical Industries Ltd

    By Type:

    • Combination

    • Progestin Only

    • Others

    By End-User:

    • Male

    • Female

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Oral Contraceptive Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Oral Contraceptive Outlook to 2028- Original Forecasts

    • 2.2 Oral Contraceptive Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Oral Contraceptive Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Oral Contraceptive Market- Recent Developments

    • 6.1 Oral Contraceptive Market News and Developments

    • 6.2 Oral Contraceptive Market Deals Landscape

    7 Oral Contraceptive Raw Materials and Cost Structure Analysis

    • 7.1 Oral Contraceptive Key Raw Materials

    • 7.2 Oral Contraceptive Price Trend of Key Raw Materials

    • 7.3 Oral Contraceptive Key Suppliers of Raw Materials

    • 7.4 Oral Contraceptive Market Concentration Rate of Raw Materials

    • 7.5 Oral Contraceptive Cost Structure Analysis

      • 7.5.1 Oral Contraceptive Raw Materials Analysis

      • 7.5.2 Oral Contraceptive Labor Cost Analysis

      • 7.5.3 Oral Contraceptive Manufacturing Expenses Analysis

    8 Global Oral Contraceptive Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Oral Contraceptive Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Oral Contraceptive Export by Region (Top 10 Countries) (2017-2028)

    9 Global Oral Contraceptive Market Outlook by Types and Applications to 2022

    • 9.1 Global Oral Contraceptive Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Combination Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Progestin Only Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Oral Contraceptive Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Male Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Female Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Oral Contraceptive Market Analysis and Outlook till 2022

    • 10.1 Global Oral Contraceptive Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Oral Contraceptive Consumption (2017-2022)

      • 10.2.2 Canada Oral Contraceptive Consumption (2017-2022)

      • 10.2.3 Mexico Oral Contraceptive Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Oral Contraceptive Consumption (2017-2022)

      • 10.3.2 UK Oral Contraceptive Consumption (2017-2022)

      • 10.3.3 Spain Oral Contraceptive Consumption (2017-2022)

      • 10.3.4 Belgium Oral Contraceptive Consumption (2017-2022)

      • 10.3.5 France Oral Contraceptive Consumption (2017-2022)

      • 10.3.6 Italy Oral Contraceptive Consumption (2017-2022)

      • 10.3.7 Denmark Oral Contraceptive Consumption (2017-2022)

      • 10.3.8 Finland Oral Contraceptive Consumption (2017-2022)

      • 10.3.9 Norway Oral Contraceptive Consumption (2017-2022)

      • 10.3.10 Sweden Oral Contraceptive Consumption (2017-2022)

      • 10.3.11 Poland Oral Contraceptive Consumption (2017-2022)

      • 10.3.12 Russia Oral Contraceptive Consumption (2017-2022)

      • 10.3.13 Turkey Oral Contraceptive Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Oral Contraceptive Consumption (2017-2022)

      • 10.4.2 Japan Oral Contraceptive Consumption (2017-2022)

      • 10.4.3 India Oral Contraceptive Consumption (2017-2022)

      • 10.4.4 South Korea Oral Contraceptive Consumption (2017-2022)

      • 10.4.5 Pakistan Oral Contraceptive Consumption (2017-2022)

      • 10.4.6 Bangladesh Oral Contraceptive Consumption (2017-2022)

      • 10.4.7 Indonesia Oral Contraceptive Consumption (2017-2022)

      • 10.4.8 Thailand Oral Contraceptive Consumption (2017-2022)

      • 10.4.9 Singapore Oral Contraceptive Consumption (2017-2022)

      • 10.4.10 Malaysia Oral Contraceptive Consumption (2017-2022)

      • 10.4.11 Philippines Oral Contraceptive Consumption (2017-2022)

      • 10.4.12 Vietnam Oral Contraceptive Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Oral Contraceptive Consumption (2017-2022)

      • 10.5.2 Colombia Oral Contraceptive Consumption (2017-2022)

      • 10.5.3 Chile Oral Contraceptive Consumption (2017-2022)

      • 10.5.4 Argentina Oral Contraceptive Consumption (2017-2022)

      • 10.5.5 Venezuela Oral Contraceptive Consumption (2017-2022)

      • 10.5.6 Peru Oral Contraceptive Consumption (2017-2022)

      • 10.5.7 Puerto Rico Oral Contraceptive Consumption (2017-2022)

      • 10.5.8 Ecuador Oral Contraceptive Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Oral Contraceptive Consumption (2017-2022)

      • 10.6.2 Kuwait Oral Contraceptive Consumption (2017-2022)

      • 10.6.3 Oman Oral Contraceptive Consumption (2017-2022)

      • 10.6.4 Qatar Oral Contraceptive Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Oral Contraceptive Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Oral Contraceptive Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Oral Contraceptive Consumption (2017-2022)

      • 10.7.2 South Africa Oral Contraceptive Consumption (2017-2022)

      • 10.7.3 Egypt Oral Contraceptive Consumption (2017-2022)

      • 10.7.4 Algeria Oral Contraceptive Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Oral Contraceptive Consumption (2017-2022)

      • 10.8.2 New Zealand Oral Contraceptive Consumption (2017-2022)

    11 Global Oral Contraceptive Competitive Analysis

    • 11.1 Janssen Global Services, LLC

      • 11.1.1 Janssen Global Services, LLC Company Details

      • 11.1.2 Janssen Global Services, LLC Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Janssen Global Services, LLC Oral Contraceptive Main Business and Markets Served

      • 11.1.4 Janssen Global Services, LLC Oral Contraceptive Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Beijing Zizhu Pharm

      • 11.2.1 Beijing Zizhu Pharm Company Details

      • 11.2.2 Beijing Zizhu Pharm Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Beijing Zizhu Pharm Oral Contraceptive Main Business and Markets Served

      • 11.2.4 Beijing Zizhu Pharm Oral Contraceptive Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Bayer AG

      • 11.3.1 Bayer AG Company Details

      • 11.3.2 Bayer AG Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Bayer AG Oral Contraceptive Main Business and Markets Served

      • 11.3.4 Bayer AG Oral Contraceptive Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Merck & Co Inc

      • 11.4.1 Merck & Co Inc Company Details

      • 11.4.2 Merck & Co Inc Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Merck & Co Inc Oral Contraceptive Main Business and Markets Served

      • 11.4.4 Merck & Co Inc Oral Contraceptive Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Mankind Pharma Ltd

      • 11.5.1 Mankind Pharma Ltd Company Details

      • 11.5.2 Mankind Pharma Ltd Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Mankind Pharma Ltd Oral Contraceptive Main Business and Markets Served

      • 11.5.4 Mankind Pharma Ltd Oral Contraceptive Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Piramal Enterprises Ltd

      • 11.6.1 Piramal Enterprises Ltd Company Details

      • 11.6.2 Piramal Enterprises Ltd Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Piramal Enterprises Ltd Oral Contraceptive Main Business and Markets Served

      • 11.6.4 Piramal Enterprises Ltd Oral Contraceptive Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Pfizer Inc

      • 11.7.1 Pfizer Inc Company Details

      • 11.7.2 Pfizer Inc Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Pfizer Inc Oral Contraceptive Main Business and Markets Served

      • 11.7.4 Pfizer Inc Oral Contraceptive Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Allergan, plc (Actavis)

      • 11.8.1 Allergan, plc (Actavis) Company Details

      • 11.8.2 Allergan, plc (Actavis) Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Allergan, plc (Actavis) Oral Contraceptive Main Business and Markets Served

      • 11.8.4 Allergan, plc (Actavis) Oral Contraceptive Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Teva Pharmaceutical Industries Ltd

      • 11.9.1 Teva Pharmaceutical Industries Ltd Company Details

      • 11.9.2 Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Teva Pharmaceutical Industries Ltd Oral Contraceptive Main Business and Markets Served

      • 11.9.4 Teva Pharmaceutical Industries Ltd Oral Contraceptive Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global Oral Contraceptive Market Outlook by Types and Applications to 2028

    • 12.1 Global Oral Contraceptive Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Combination Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Progestin Only Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Oral Contraceptive Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Male Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Female Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Oral Contraceptive Market Analysis and Outlook to 2028

    • 13.1 Global Oral Contraceptive Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.2.2 Canada Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Oral Contraceptive Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.3.2 UK Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.3.3 Spain Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.3.5 France Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.3.6 Italy Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.3.8 Finland Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.3.9 Norway Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.3.11 Poland Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.3.12 Russia Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Oral Contraceptive Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.4.2 Japan Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.4.3 India Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Oral Contraceptive Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.5.3 Chile Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.5.6 Peru Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Oral Contraceptive Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.6.3 Oman Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Oral Contraceptive Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Oral Contraceptive Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Oral Contraceptive Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Oral Contraceptive Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Oral Contraceptive

    • Figure of Oral Contraceptive Picture

    • Table Global Oral Contraceptive Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Oral Contraceptive Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Combination Consumption and Growth Rate (2017-2022)

    • Figure Global Progestin Only Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Male Consumption and Growth Rate (2017-2022)

    • Figure Global Female Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Contraceptive Consumption by Country (2017-2022)

    • Table North America Oral Contraceptive Consumption by Country (2017-2022)

    • Figure United States Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Canada Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Mexico Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Table Europe Oral Contraceptive Consumption by Country (2017-2022)

    • Figure Germany Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure UK Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Spain Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Belgium Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure France Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Italy Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Denmark Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Finland Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Norway Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Sweden Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Poland Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Russia Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Turkey Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Table APAC Oral Contraceptive Consumption by Country (2017-2022)

    • Figure China Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Japan Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure India Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure South Korea Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Thailand Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Singapore Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Philippines Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Table South America Oral Contraceptive Consumption by Country (2017-2022)

    • Figure Brazil Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Colombia Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Chile Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Argentina Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Peru Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Table GCC Oral Contraceptive Consumption by Country (2017-2022)

    • Figure Bahrain Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Oman Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Qatar Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Table Africa Oral Contraceptive Consumption by Country (2017-2022)

    • Figure Nigeria Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure South Africa Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Egypt Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Algeria Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Table Oceania Oral Contraceptive Consumption by Country (2017-2022)

    • Figure Australia Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Table Janssen Global Services, LLC Company Details

    • Table Janssen Global Services, LLC Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Global Services, LLC Oral Contraceptive Main Business and Markets Served

    • Table Janssen Global Services, LLC Oral Contraceptive Product Portfolio

    • Table Beijing Zizhu Pharm Company Details

    • Table Beijing Zizhu Pharm Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Zizhu Pharm Oral Contraceptive Main Business and Markets Served

    • Table Beijing Zizhu Pharm Oral Contraceptive Product Portfolio

    • Table Bayer AG Company Details

    • Table Bayer AG Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Oral Contraceptive Main Business and Markets Served

    • Table Bayer AG Oral Contraceptive Product Portfolio

    • Table Merck & Co Inc Company Details

    • Table Merck & Co Inc Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Oral Contraceptive Main Business and Markets Served

    • Table Merck & Co Inc Oral Contraceptive Product Portfolio

    • Table Mankind Pharma Ltd Company Details

    • Table Mankind Pharma Ltd Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mankind Pharma Ltd Oral Contraceptive Main Business and Markets Served

    • Table Mankind Pharma Ltd Oral Contraceptive Product Portfolio

    • Table Piramal Enterprises Ltd Company Details

    • Table Piramal Enterprises Ltd Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Piramal Enterprises Ltd Oral Contraceptive Main Business and Markets Served

    • Table Piramal Enterprises Ltd Oral Contraceptive Product Portfolio

    • Table Pfizer Inc Company Details

    • Table Pfizer Inc Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Oral Contraceptive Main Business and Markets Served

    • Table Pfizer Inc Oral Contraceptive Product Portfolio

    • Table Allergan, plc (Actavis) Company Details

    • Table Allergan, plc (Actavis) Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan, plc (Actavis) Oral Contraceptive Main Business and Markets Served

    • Table Allergan, plc (Actavis) Oral Contraceptive Product Portfolio

    • Table Teva Pharmaceutical Industries Ltd Company Details

    • Table Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Oral Contraceptive Main Business and Markets Served

    • Table Teva Pharmaceutical Industries Ltd Oral Contraceptive Product Portfolio

    • Figure Global Combination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Progestin Only Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Male Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Female Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Contraceptive Consumption Forecast by Country (2022-2028)

    • Table North America Oral Contraceptive Consumption Forecast by Country (2022-2028)

    • Figure United States Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Oral Contraceptive Consumption Forecast by Country (2022-2028)

    • Figure Germany Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Oral Contraceptive Consumption Forecast by Country (2022-2028)

    • Figure China Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Oral Contraceptive Consumption Forecast by Country (2022-2028)

    • Figure Brazil Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Oral Contraceptive Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Oral Contraceptive Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Oral Contraceptive Consumption Forecast by Country (2022-2028)

    • Figure Australia Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US